Pharmaceutical

Korro Bio enters merger deal with Frequency Therapeutics

Korro Bio has signed a definitive merger agreement with Frequency Therapeutics to create a genetic medicines firm.

Jul 17, 2023 - 20:00
Korro Bio enters merger deal with Frequency Therapeutics
Korro Bio has signed a definitive merger agreement with Frequency Therapeutics to create a genetic medicines firm.
Read the original article

Tags:

Previous Article

Vivoryon issues updates on its Alzheimer’s therapy programme

Next Article

Lilly to acquire biopharma firm Versanis for $1.9bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves first RSV vaccine, a long-sought scientific achievement

FDA approves first RSV vaccine, a long-sought scientifi...

May 3, 2023

STAT+: Novo says oral version of Ozempic leads to 15% weight loss

STAT+: Novo says oral version of Ozempic leads to 15% w...

May 23, 2023

KKM-191-D by Genuone Science for Type 2 Diabetes: Likel...

Aug 10, 2023